|
|
|
Volumn 146, Issue 4, 2003, Pages
|
|
Platelet activation after stenting with heparin-coated versus noncoated stents.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
BIOLOGICAL MARKER;
FIBRINOGEN RECEPTOR;
GLYCOPROTEIN IIB;
HEPARIN;
PAC1 PHOSPHATASE;
PADGEM PROTEIN;
PROTEIN TYROSINE PHOSPHATASE;
AGED;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
MALE;
METABOLISM;
PHYSIOLOGY;
PILOT STUDY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
STENT;
THROMBOCYTE;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION;
AGED;
ANTICOAGULANTS;
ASPIRIN;
BIOLOGICAL MARKERS;
BLOOD PLATELETS;
FEMALE;
FLOW CYTOMETRY;
HEPARIN;
HUMANS;
MALE;
P-SELECTIN;
PILOT PROJECTS;
PLATELET ACTIVATION;
PLATELET AGGREGATION;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PLATELET MEMBRANE GLYCOPROTEIN IIB;
PROSPECTIVE STUDIES;
PROTEIN-TYROSINE-PHOSPHATASE;
STENTS;
|
|
EID: 0142186281
PISSN: None
EISSN: 10976744
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
